ZA891402B - 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion - Google Patents

4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion

Info

Publication number
ZA891402B
ZA891402B ZA891402A ZA891402A ZA891402B ZA 891402 B ZA891402 B ZA 891402B ZA 891402 A ZA891402 A ZA 891402A ZA 891402 A ZA891402 A ZA 891402A ZA 891402 B ZA891402 B ZA 891402B
Authority
ZA
South Africa
Prior art keywords
qyuinoline
acyl
inhibitors
derivatives
amino
Prior art date
Application number
ZA891402A
Inventor
Robert John Ife
John Ife Robert
Thomas Henry Brown
Henry Brown Thomas
Colin Andrew Leach
Andrew Leach Colin
Original Assignee
Smithkline Beckman Intercredit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Intercredit filed Critical Smithkline Beckman Intercredit
Publication of ZA891402B publication Critical patent/ZA891402B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA891402A 1988-02-25 1989-02-23 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion ZA891402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888804444A GB8804444D0 (en) 1988-02-25 1988-02-25 Compounds

Publications (1)

Publication Number Publication Date
ZA891402B true ZA891402B (en) 1990-09-26

Family

ID=10632376

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891402A ZA891402B (en) 1988-02-25 1989-02-23 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion

Country Status (22)

Country Link
US (1) US5089504A (en)
EP (1) EP0330485B1 (en)
JP (1) JPH0774204B2 (en)
KR (1) KR0159083B1 (en)
CN (2) CN1027368C (en)
AU (1) AU606508B2 (en)
CA (1) CA1332839C (en)
CZ (1) CZ398391A3 (en)
DE (1) DE68906687T2 (en)
DK (1) DK166623B1 (en)
ES (1) ES2055037T3 (en)
FI (1) FI93952C (en)
GB (1) GB8804444D0 (en)
HU (1) HU208814B (en)
IE (1) IE63239B1 (en)
IL (1) IL89346A (en)
MY (1) MY105158A (en)
NZ (1) NZ228098A (en)
PT (1) PT89789B (en)
WO (1) WO1989008104A1 (en)
ZA (1) ZA891402B (en)
ZW (1) ZW1989A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
JPH04211661A (en) * 1990-03-28 1992-08-03 Otsuka Pharmaceut Co Ltd Quinoline derivative and anti-ulcer agent containing the same
HUT67609A (en) * 1991-01-29 1995-04-28 Smithkline Beecham Intercredit Salts of a 4-amino-3-acyl-quinoline derivative, their preparation and pharmaceutical compositions comprising them
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (en) * 1993-06-11 1994-12-12 Ab Astra Compounds that inhibit gastric acid flow
SE9302005D0 (en) 1993-06-11 1993-06-11 Ab Astra NEW ACTIVE COMPOUNDS
EP1086094A1 (en) 1998-05-23 2001-03-28 Byk Gulden Lomberg Chemische Fabrik GmbH Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
HN2000000203A (en) 1999-11-30 2001-06-13 Pfizer Prod Inc PROCEDURE FOR OBTAINING 1,2,3,4-TETRAHYDROQUINOLINS 4-CARBOXYAMIN-2-SUBSTITUTED.
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
ME00524B (en) 2003-03-10 2011-10-10 Astrazeneca Ab Novel process for the preparation of roflumilast
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
CN106496119A (en) * 2016-10-17 2017-03-15 江南大学 A kind of preparation method of 8 aminoquinoline of N phenyl

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2652398A (en) * 1949-11-17 1953-09-15 Endo Products Inc N-substituted-2-amino (methyl) quinolines
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
ZA801526B (en) * 1979-03-26 1981-08-26 Robins Co Inc A H 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds

Also Published As

Publication number Publication date
DK166623B1 (en) 1993-06-21
CA1332839C (en) 1994-11-01
WO1989008104A1 (en) 1989-09-08
FI93952C (en) 1995-06-26
GB8804444D0 (en) 1988-03-23
HUT53086A (en) 1990-09-28
HU208814B (en) 1994-01-28
IE63239B1 (en) 1995-04-05
HU891463D0 (en) 1990-01-28
CN1100414A (en) 1995-03-22
ES2055037T3 (en) 1994-08-16
NZ228098A (en) 1990-10-26
AU3181989A (en) 1989-09-22
ZW1989A1 (en) 1989-09-13
KR900700457A (en) 1990-08-13
JPH02503318A (en) 1990-10-11
FI895048A0 (en) 1989-10-24
JPH0774204B2 (en) 1995-08-09
CZ398391A3 (en) 1994-05-18
US5089504A (en) 1992-02-18
DK528889A (en) 1989-10-24
AU606508B2 (en) 1991-02-07
PT89789B (en) 1994-05-31
DK528889D0 (en) 1989-10-24
PT89789A (en) 1989-10-04
EP0330485B1 (en) 1993-05-26
KR0159083B1 (en) 1998-12-01
FI93952B (en) 1995-03-15
IL89346A (en) 1994-01-25
DE68906687T2 (en) 1993-12-02
EP0330485A1 (en) 1989-08-30
CN1035501A (en) 1989-09-13
IE890568L (en) 1989-08-25
CN1027368C (en) 1995-01-11
DE68906687D1 (en) 1993-07-01
MY105158A (en) 1994-08-30

Similar Documents

Publication Publication Date Title
ZA891402B (en) 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion
EG18128A (en) Process for preparation of substituted thienoimidazole derivatives and their use as inhibitors of gastric acid secretion
EP0532466A3 (en) Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
NZ224361A (en) Preparation of (6s)-folinic acid and its salts
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
EP0273689A3 (en) Derivatives of n-(2-alkyl-3-mercapto-glutaryl) alpha-amino acids and their use as collagenase inhibitors
HU893412D0 (en) Inhibitors of interleucin-1
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
IL89534A0 (en) Preparation of 1-cyclopropyl-quinolone-carboxylic acids and derivatives thereof and certain novel n-cyclopropyl-anilines used therein
ZA891442B (en) Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion
ZA855030B (en) Benzimadzoles,benzoxales,benzothiazoles and their production,formulation and use as gastric acid secretion inhibitors
GB8813796D0 (en) Use of dioxopiperidine derivatives as analgesics
HU9302201D0 (en) Salts of 4-amino-3-acyl-quinoline derivatives and their application for hindering secretion of gastric acid
AU7465487A (en) Benzimidazole derivatives and their use as gastric acid secretion inhibitors
NZ217322A (en) Toluidine derivatives and gastric acid inhibitor compositions
AU3494293A (en) Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
PH25869A (en) Catechol carboxylic acid derivatives and compositions thereof
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
ZA929568B (en) 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion
AU582255B2 (en) Embonates of quinolonecarboxylic acids and of their derivatives
IL87428A0 (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors
ZA867827B (en) Benzimadazoles,benzoxazoles,benzothiazoles and their production,formulation and use as gastric acid secretion inhibitors
GB2206579B (en) 6a and 6b-(substituted methyl)-penicillanic acid derivatives
DE3474912D1 (en) Use of 2-pentanoylaminoacetic acid and salts thereof